Apc-mutant Kyoto Apc Delta (KAD) rats are susceptible to 4-NQO-induced tongue carcinogenesis

Cancers

Volumn 6, Issue 3, 2014, Pages 1522-1539

  Tanaka, Takuji ^a,b   Shimizu, Masahito ^b   Kochi, Takahiro ^b   Shirakami, Yohei ^b   Mori, Takayuki ^c   Watanabe, Naoki ^a   Naiki, Takafumi ^a   Moriwaki, Hisataka ^b   Yoshimi, Kazuto ^d   Serikawa, Tadao ^d   Kuramoto, Takashi ^d  

^a Gifu Municipal Hospital   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OGAKI MUNICIPAL HOSPITAL   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Apc mutant rats; Carcinogenesis; Inflammation; Susceptibility; Tongue

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CELL DENSITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FISCHER 344 RAT; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KYOTO APC DELTA RAT; MALE; MAST CELL; MOUTH MUCOSA; MUTANT RAT STRAIN; NONHUMAN; NS1C RAT; RAT; RAT STRAIN; STRAIN DIFFERENCE; TONGUE CARCINOMA;

EID: 84904796952     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers6031522     Document Type: Article

References (50)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M.J. Cancer statistics. CA Cancer J. Clin. 2009, 59, 225-249.
2. Choi, S.; Myers, J.N. Molecular pathogenesis of oral squamous cell carcinoma: Implications for therapy. J. Dent. Res. 2008, 87, 14-32.
3. Hooper, S.J.; Wilson, M.J.; Crean, S.J. Exploring the link between microorganisms and oral cancer: A systematic review of the literature. Head Neck 2009, 31, 1228-1239.
4. Meurman, J.H.; Uittamo, J. Oral micro-organisms in the etiology of cancer. Acta Odontol. Scand. 2008, 66, 321-326.
5. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nature 2008, 454, 436-444.
6. Sethi, G.; Sung, B.; Aggarwal, B.B. TNF: A master switch for inflammation to cancer. Front. Biosci. 2008, 13, 5094-5107.
7. Balkwill, F.; Mantovani, A. Inflammation and cancer: Back to Virchow? Lancet 2001, 357, 539-545.
8. Heidland, A.; Klassen, A.; Rutkowski, P.; Bahner, U. The contribution of Rudolf Virchow to the concept of inflammation: What is still of importance? J. Nephrol. 2006, 19, S102-S109.
9. Schmidt, A.; Weber, O.F. In memoriam of Rudolf virchow: A historical retrospective including aspects of inflammation, infection and neoplasia. Contrib. Microbiol. 2006, 13, 1-15.
10. Balkwill, F.; Charles, K.A.; Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005, 7, 211-217.
11. Tanaka, T. Inflammation and cancer. In Disease Progression and Chemoprevention; Tanaka, T., Ed.; Research Signpost: Kerala, India, 2007; pp. 27-44.
12. Tanaka, T. Introduction for inflammation and cancer. Semin. Immunopathol. 2013, 35, 121-122.
13. Tanaka, T.; Shimizu, M.; Kochi, T.; Moriwaki, H. Chemical-induced Carcinogenesis. J. Exp. Clin. Med. 2013, 5, 203-209.
14. Feller, L.; Altini, M.; Lemmer, J. Inflammation in the context of oral cancer. Oral Oncol. 2013, 49, 887-892.
15. Forrest, J.L.; Horowitz, A.M.; Shmuely, Y. Dental hygienists' knowledge, opinions, and practices related to oral and pharyngeal cancer risk assessment. J. Dent. Hyg. 2001, 75, 271-281.
16. Meurman, J.H. Infectious and dietary risk factors of oral cancer. Oral Oncol. 2010, 46, 411-413.
17. Beroud, C.; Soussi, T. APC gene: Database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res. 1996, 24, 121-124.
18. Groden, J.; Thliveris, A.; Samowitz, W.; Carlson, M.; Gelbert, L.; Albertsen, H.; Joslyn, G.; Stevens, J.; Spirio, L.; Robertson, M.; et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66, 589-600.
19. Evers, C.; Gaspar, H.; Kloor, M.; Bozukova, G.; Kadmon, M.; Keller, M.; Sutter, C.; Moog, U. Hepatoblastoma in two siblings and familial adenomatous polyposis: Causal nexus or coincidence? Fam. Cancer 2012, 11, 529-533.
20. Tamura, G. Molecular pathogenesis of adenoma and differentiated adenocarcinoma of the stomach. Pathol. Int. 1996, 46, 834-841.
21. Imai, F.L.; Uzawa, K.; Shiiba, M.; Watanabe, T.; Miya, T.; Kubosawa, H.; Kondo, Y.; Tanzawa, H. Evidence of multi-step oncogenesis of oral squamous cell carcinoma. Oncol. Rep. 1998, 5, 1489-1491.
22. Kannan, S.; Yokozaki, H.; Jayasree, K.; Sebastian, P.; Mathews, A.; Abraham, E.K.; Nair, M.K.; Tahara, E. Infrequent loss of heterozygosity of the major tumour suppressor genes in Indian oral cancers. Int. J. Oral Maxillofac. Surg. 2002, 31, 414-418.
23. Liao, P.H.; Lee, T.L.; Yang, L.C.; Yang, S.H.; Chen, S.L.; Chou, M.Y. Adenomatous polyposis coli gene mutation and decreased wild-type p53 protein expression in oral submucous fibrosis: A preliminary investigation. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2001, 92, 202-207.
24. Pannone, G.; Bufo, P.; Santoro, A.; Franco, R.; Aquino, G.; Longo, F.; Botti, G.; Serpico, R.; Cafarelli, B.; Abbruzzese, A.; et al. WNT pathway in oral cancer: Epigenetic inactivation of WNT-inhibitors. Oncol. Rep. 2010, 24, 1035-1041.
25. Yeh, K.T.; Chang, J.G.; Lin, T.H.; Wang, Y.F.; Chang, J.Y.; Shih, M.C.; Lin, C.C. Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer. Int. J. Oncol. 2003, 23, 1001-1007.
26. Yoshimi, K.; Tanaka, T.; Takizawa, A.; Kato, M.; Hirabayashi, M.; Mashimo, T.; Serikawa, T.; Kuramoto, T. Enhanced colitis-associated colon carcinogenesis in a novel Apc mutant rat. Cancer Sci. 2009, 100, 2022-2027.
27. Yoshimi, K.; Hashimoto, T.; Niwa, Y.; Hata, K.; Serikawa, T.; Tanaka, T.; Kuramoto, T. Use of a chemically induced-colon carcinogenesis-prone Apc-mutant rat in a chemotherapeutic bioassay. BMC Cancer 2012, 12, 448.
28. Yoshimi, K.; Tanaka, T.; Serikawa, T.; Kuramoto, T. Tumor suppressor APC protein is essential in mucosal repair from colonic inflammation through angiogenesis. Am. J. Pathol. 2013, 182, 1263-1274.
29. Tanaka, T.; Ishigamori, R. Understanding carcinogenesis for fighting oral cancer. J. Oncol. 2011, 2011, 603740.
30. Tanaka, T.; Tanaka, M. Oral carcinogenesis and oral cancer chemoprevention: A review. Patholog. Res. Int. 2011, 2011, 431246.
31. Van der Meij, E.H.; Mast, H.; van der Waal, I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: A prospective five-year follow-up study of 192 patients. Oral Oncol. 2007, 43, 742-748.
32. Liu, Y.; Messadi, D.V.; Wu, H.; Hu, S. Oral lichen planus is a unique disease model for studying chronic inflammation and oral cancer. Med. Hypotheses 2010, 75, 492-494.
33. Khatri, M.J.; Desai, R.S.; Mamatha, G.S.; Kukarni, M.; Khatri, J. Immunohistochemical expression of mast cells using c-Kit in various grades of oral submucous fibrosis. ISRN Pathology 2013, 2013, Article ID 543976.
34. Iamaroon, A.; Pongsiriwet, S.; Jittidecharaks, S.; Pattanaporn, K.; Prapayasatok, S.; Wanachantararak, S. Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J. Oral Pathol. Med. 2003, 32, 195-199.
35. Ranieri, G.; Labriola, A.; Achille, G.; Florio, G.; Zito, A.F.; Grammatica, L.; Paradiso, A. Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. Int. J. Oncol. 2002, 21, 1317-1323.
36. Aromando, R.F.; Perez, M.A.; Heber, E.M.; Trivillin, V.A.; Tomasi, V.H.; Schwint, A.E.; Itoiz, M.E. Potential role of mast cells in hamster cheek pouch carcinogenesis. Oral Oncol. 2008, 44, 1080-1087.
37. Tanaka, T.; Ishikawa, H. Mast cells and inflammation-associated colorectal carcinogenesis. Semin. Immunopathol. 2013, 35, 245-254.
38. Eckert, A.W.; Schutze, A.; Lautner, M.H.; Taubert, H.; Schubert, J.; Bilkenroth, U. HIF-1α is a prognostic marker in oral squamous cell carcinomas. Int. J. Biol. Markers 2010, 25, 87-92.
39. Karin, M.; Greten, F.R. NF-κB: Linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005, 5, 749-759.
40. Nagini, S.; Letchoumy, P.V.; A, T.; Cr, R. Of humans and hamsters: A comparative evaluation of carcinogen activation, DNA damage, cell proliferation, apoptosis, invasion, and angiogenesis in oral cancer patients and hamster buccal pouch carcinomas. Oral Oncol. 2009, 45, e31-37.
41. Gerhauser, C. Cancer chemoprevention and nutriepigenetics: State of the art and future challenges. Top. Curr. Chem. 2013, 329, 73-132.
42. Kimbro, K.S.; Simons, J.W. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr. Relat. Cancer 2006, 13, 739-749.
43. Shirakami, Y.; Shimizu, M.; Moriwaki, H. Cancer chemoprevention with green tea catechins: From bench to bed. Curr. Drug Targets 2012, 13, 1842-1857.
44. Jablonska, E.; Piotrowski, L.; Grabowska, Z. Serum levels of IL-1β, IL-6, TNF-α, sTNF-RI and CRP in patients with oral cavity cancer. Pathol. Oncol. Res. 1997, 3, 126-129.
45. Elashoff, D.; Zhou, H.; Reiss, J.; Wang, J.; Xiao, H.; Henson, B.; Hu, S.; Arellano, M.; Sinha, U.; Le, A.; et al. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol. Biomarkers Prev. 2012, 21, 664-672.
46. Prasad, G.; McCullough, M. Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral cancer. Int. J. Dent. 2013, 2013, 813756.
47. Aivaliotis, I.L.; Pateras, I.S.; Papaioannou, M.; Glytsou, C.; Kontzoglou, K.; Johnson, E.O.; Zoumpourlis, V. How do cytokines trigger genomic instability? J. Biomed. Biotechnol. 2012, 2012, 536761.
48. Suzuki, R.; Kohno, H.; Suzui, M.; Yoshimi, N.; Tsuda, H.; Wakabayashi, K.; Tanaka, T. An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: Its potential use for preclinical chemoprevention studies. Carcinogenesis 2006, 27, 619-630.
49. Tanaka, T.; Kohno, H.; Nomura, E.; Taniguchi, H.; Tsuno, T.; Tsuda, H. A novel geranylated derivative, ethyl 3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate, synthesized from ferulic acid suppresses carcinogenesis and inducible nitric oxide synthase in rat tongue. Oncology 2003, 64, 166-175.
50. Yoshida, K.; Tanaka, T.; Kohno, H.; Sakata, K.; Kawamori, T.; Mori, H.; Wakabayashi, K. A COX-2 inhibitor, nimesulide, inhibits chemically-induced rat tongue carcinogenesis through suppression of cell proliferation activity and COX-2 and iNOS expression. Histol. Histopathol. 2003, 18, 39-48.